[Acute myelogenous leukemia associated with severe esophageal stricture after chemotherapy]

Rinsho Ketsueki. 2002 Jan;43(1):41-3.
[Article in Japanese]

Abstract

A 41-year-old woman with relapsed acute myelogenous leukemia was treated twice with idarubicin hydrochloride and cytarabine. She developed a 6-cm-long stricture in the lower esophagus 12 days after re-induction therapy. Although she had preceding candida infection, it is suspected that her stricture was caused by mucosal damage due to chemotherapeutic agents. This case suggests that the possibility of esophageal stricture should be considered in patients with swallowing disturbance after intensive chemotherapy.

Publication types

  • Case Reports
  • English Abstract
  • Review

MeSH terms

  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Cytarabine / administration & dosage
  • Cytarabine / adverse effects
  • Esophageal Stenosis / chemically induced*
  • Female
  • Humans
  • Idarubicin / administration & dosage
  • Idarubicin / adverse effects
  • Leukemia, Myeloid, Acute / drug therapy*

Substances

  • Cytarabine
  • Idarubicin